The long and winding road to optimal HbA1c measurement

Clinica Chimica Acta

Volumn 418, Issue , 2013, Pages 63-71

  Little, Randie R ^a   Rohlfing, Curt L ^a  

^a University of Missouri   (United States)

Author keywords

Diabetes; Glycated hemoglobin; HbA1c; Standardization

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

BLOOD GLUCOSE MONITORING; CLINICAL CHEMISTRY; DIABETES MELLITUS; DIAGNOSTIC VALUE; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; LIMIT OF DETECTION; OUTCOME ASSESSMENT; POINT OF CARE TESTING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REFERENCE VALUE; REVIEW; STANDARDIZATION;

DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 84873203148     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.12.026     Document Type: Review

References (70)

1. World Health Organization, WHO Diabetes Media centre. 2012. http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
2. DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
3. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-851.
4. Baynes J.W., Bunn H.F., Goldstein D., et al. National Diabetes Data Group: report of the expert committee on glucosylated hemoglobin. Diabetes Care 1984, 7:602-606.
5. Little R.R., Wiedmeyer H.M., England J.D., Naito H.K., Goldstein D.E. Interlaboratory comparison of glycohemoglobin results: College of American Pathologists Survey data. Clin Chem 1991, 37:1725-1729.
6. Weykamp C.W., Penders T.J., Miedema K., Muskiet F.A., van der Slik W. Standardization of glycohemoglobin results and reference values in whole blood studied in 103 laboratories using 20 methods. Clin Chem 1995, 41:82-86.
7. Kunkel H.G., Wallenius G. New hemoglobin in normal adult blood. Science 1955, 122:288.
8. Huisman T.H. Studies on the heterogeneity of hemoglobin. XI. Chromatographic studies of intermediate forms of oxy- and ferrihemoglobin. Arch Biochem Biophys 1966, 113:427-434.
9. Schroeder W.A., Holmquist W.R. Structural chemistry and molecular biology 1968, (San Francisco). A. Rich, N. Davidson (Eds.).
10. Clegg M.D., Schroeder W.A. A chromatographic study of the minor components of normal adult human hemoglobin. J Am Chem Soc 1959, 81:6065-6069.
11. Rahbar S. An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta 1968, 22:296-298.
12. Bookchin R.M., Gallop P.M. Structure of hemoglobin AIc: nature of the N-terminal beta chain blocking group. Biochem Biophys Res Commun 1968, 32:86-93.
13. Bunn H.F. Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med 1981, 70:325-330.
14. Shapiro R., McManus M.J., Zalut C., Bunn H.F. Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem 1980, 255:3120-3127.
15. Bunn H.F., Haney D.N., Gabbay K.H., Gallop P.M. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun 1975, 67:103-109.
16. Mallia A.K., Hermanson G.T., Krohn R.I., Fujimoto E.K., Smith P.K. Preparation and use of a boronic acid affinity support for separation and quantitation of glycosylated hemoglobins. Anal Lett 1981, 14:649-661.
17. Klenk D.C., Hermanson G.T., Krohn R.I., et al. Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clin Chem 1982, 28:2088-2094.
18. Tahara Y., Shima K. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care 1993, 16:1313-1314.
19. Trivelli L.A., Ranney H.M., Lai H.T. Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971, 284:353-357.
20. Lauritzen T., Frost-Larsen K., Larsen H.W., Deckert T. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985, 34(Suppl. 3):74-79.
21. Feldt-Rasmussen B., Mathiesen E.R., Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986, 2:1300-1304.
22. Feldt-Rasmussen B., Mathiesen E.R., Jensen T., Lauritzen T., Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 1991, 34:164-170.
23. Reichard P., Berglund B., Britz A., Cars I., Nilsson B.Y., Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5years. J Intern Med 1991, 230:101-108.
24. Brinchmann-Hansen O., Dahl-Jorgensen K., Sandvik L., Hanssen K.F. Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study. BMJ 1992, 304:19-22.
25. Alberti K.G.M.M., Gries F.A. Management of non-insulin-dependent diabetes mellitus in Europe: a consensus view. Diabet Med 1988, 5:275-281.
26. CAP Electrophoresis chromatography survey set EC-A CAP 1993.
27. Little R.R., England J.D., Wiedmeyer H.M., et al. Interlaboratory standardization of glycated hemoglobin determinations. Clin Chem 1986, 32:358-360.
28. Little R.R., Wiedmeyer H.M., England J.D., et al. Interlaboratory standardization of measurements of glycohemoglobins. Clin Chem 1992, 38:2472-2478.
29. Myers G.L., Kimberly M.M., Waymack P.P., Smith S.J., Cooper G.R., Sampson E.J. A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000, 46:1762-1772.
30. American Diabetes Association Implications of the Diabetes Control and Complications Trial. Diabetes Care 1993, 16:1517-1520.
31. NGSP NGSP protocol overview 2012, http://www.ngsp.org/docs/Protocol.pdf.
32. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Off JL 1998, 331:1-37.
33. Joint commission on traceability in laboratory medicine 2012, http://www.bipm.org/en/committees/jc/jctlm/.
34. Jeppsson J.O., Kobold U., Barr J., et al. Approved IFCC reference method for the measurement of HbA1c in human blood. Clin Chem Lab Med 2002, 40:78-89.
35. Weykamp C., John W.G., Mosca A., et al. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem 2008, 54:240-248.
36. IFCC network on HbA1c 2012, http://www.ifcchba1c.com/.
37. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007, 30:2399-2400.
38. Nathan D.M., Kuenen J., Borg R., et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008, 31:1473-1478.
39. Barth J.H., Marshall S.M., Watson I.D. Consensus meeting on reporting glycated haemoglobin and estimated average glucose in the UK: report to the National Director for Diabetes, Department of Health. Ann Clin Biochem 2008, 45:343-344.
40. Hanas R., John G. 2010 consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Clin Chem 2010, 56:1362-1364.
41. Hanas R. Psychological impact of changing the scale of reported HbA(1c) results affects metabolic control. Diabetes Care 2002, 25:2110-2111.
42. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197.
43. International Expert Committee International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
44. American Diabetes Association Standards of medical care in diabetes 2010. Diabetes Care 2010, 33:S11-S61.
45. WHO Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation 2011.
46. AACE/ACE American Association of Clinical Endocrinologists/American College of Endocrinology statement on the use of hemoglobin A1c for the diagnosis of diabetes. Endocr Pract 2010, 16:155-156.
47. Bonora E., Tuomilehto J., Bonora E., Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011, 34(Suppl. 2):S184-S190.
48. NGSP Certified methods and laboratories 2012, http://www.ngsp.org/certified.asp.
49. American Diabetes Association Standards of medical care in diabetes - 2009. Diabetes Care 2009, 32(Suppl. 1):S13-S61.
50. National Institute for Health and Clinical Excellence (NICE) Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes 2012, http://www.nice.org.uk/nicemedia/live/12165/44318/44318.pdf.
51. Lind M., Oden A., Fahlen M., Eliasson B. The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects. Diabetologia 2010, 53:1093-1098.
52. Sacks D.B., Arnold M., Bakris G.L., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011, 34:e61-e99.
53. Lenters-Westra E., Slingerland R.J. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010, 56:44-52.
54. Herman W.H., Ma Y., Uwaifo G., et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007, 30:2453-2457.
55. Pani L.N., Korenda L., Meigs J.B., et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008, 31:1991-1996.
56. Wiener K., Roberts N.B. Age does not influence levels of HbA1c in normal subject. Q J Med 1999, 92:169-173.
57. Bry L., Chen P.C., Sacks D.B. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin [Review]. Clin Chem 2001, 47:153-163.
58. NGSP HbA1c assay interferences 2012, http://www.ngsp.org/interf.asp.
59. Little R.R., Rohlfing C.L., Hanson S.E., et al. The effect of increased fetal hemoglobin on 7 common HbA1c assay methods. Clin Chem 2012, 58:945-947.
60. Scuderi R.T., Griffin T.L., Mehta S.P., Herold D.A., Fitzgerald R.L. Interference with hemoglobin A(1C) determination by the hemoglobin variant Shelby. Am J Clin Pathol 2007, 128:440-444.
61. Nyenwe E.A., Fisher J.N. A mistaken diagnosis of type 2 diabetes due to hemoglobin N-Baltimore. Am J Med Sci 2008, 336:524-526.
62. Jain N., Kesimer M., Hoyer J.D., et al. Hemoglobin Raleigh results in factitiously low hemoglobin A1c when evaluated via immunoassay analyzer. J Diabetes Complications 2011, 25:14-18.
63. van den Ouweland J.M., van Daal H., Klaassen C.H., van Aarssen Y., Harteveld C.L., Giordano P.C. The silent hemoglobin alpha chain variant Hb Riccarton [alpha51(CE9)Gly→Ser] may affect HbA1c determination on the HLC-723G7 analyzer. Clin Chem Lab Med 2008, 46:827-830.
64. Peacock T.P., Shihabi Z.K., Bleyer A.J., et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 2008, 73:1062-1068.
65. Inaba M., Okuno S., Kumeda Y., et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007, 18:896-903.
66. Freedman B.I., Shenoy R.N., Planer J.A., et al. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int 2010, 30:72-79.
67. Tarim O., Kucukerdogan A., Gunay U., Eralp O., Ercan I. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int 1999, 41:357-362.
68. Coban E., Ozdogan M., Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 2004, 112:126-128.
69. Sundaram R.C., Selvaraj N., Vijayan G., Bobby Z., Hamide A., Rattina Dasse N. Increased plasma malondialdehyde and fructosamine in iron deficiency anemia: effect of treatment. Biomed Pharmacother 2007, 61:682-685.
70. Bloomgarden Z.T. Glycemic control in diabetes: a tale of three studies. Diabetes Care 2008, 31:1913-1919.